Management of severe community-acquired pneumonia of children in developing and developed countries
- PMID: 20965930
- DOI: 10.1136/thx.2010.142604
Management of severe community-acquired pneumonia of children in developing and developed countries
Abstract
Childhood community-acquired pneumonia (CAP) is common, and recent data have shown that the number of children with severe CAP is increasing worldwide. Regardless of geographical area, severe cases are those at the highest risk of hospitalisation, prolonged hospitalisation and death, and therefore require prompt identification and the most effective treatment in order to reduce CAP-related morbidity and mortality. This review evaluates the available data concerning the diagnosis and treatment of severe and/or complicated cases of paediatric CAP in developed and developing countries. It also underlines the fact that any evidence-based recommendations require more research in various areas, including the aetiology of severe cases and the reasons for the complications, the better definition of first-choice antibiotic treatment and when surgery may be useful, and the role of chest physiotherapy.
Comment in
-
Childhood immunisation with conjugate vaccines and prevention of pneumonia.Thorax. 2012 Jan;67(1):83; author reply 83-4. doi: 10.1136/thx.2011.159244. Epub 2011 Apr 17. Thorax. 2012. PMID: 21502094 No abstract available.
-
Necrotising pneumonia, pneumatoceles and the pneumococcus.Thorax. 2012 Oct;67(10):925; author reply 925-6. doi: 10.1136/thoraxjnl-2011-201308. Epub 2012 Feb 16. Thorax. 2012. PMID: 22343709 No abstract available.
Similar articles
-
Severe community-acquired pneumonia.Infect Dis Clin North Am. 2009 Sep;23(3):503-20. doi: 10.1016/j.idc.2009.04.003. Infect Dis Clin North Am. 2009. PMID: 19665080 Review.
-
Community-acquired pneumonia: a review and recent advances.Pediatr Pulmonol. 2007 Dec;42(12):1095-103. doi: 10.1002/ppul.20652. Pediatr Pulmonol. 2007. PMID: 17588246 Review.
-
Community-acquired pneumonia in HIV-infected children: a global perspective.Curr Opin Pulm Med. 2010 May;16(3):208-16. doi: 10.1097/MCP.0b013e3283387984. Curr Opin Pulm Med. 2010. PMID: 20375782 Review.
-
Antibiotic therapy for pediatric community-acquired pneumonia: do we know when, what and for how long to treat?Pediatr Infect Dis J. 2012 Jun;31(6):e78-85. doi: 10.1097/INF.0b013e318255dc5b. Pediatr Infect Dis J. 2012. PMID: 22466326 Review.
-
[Community-acquired pneumonia].Arch Bronconeumol. 2010 Oct;46 Suppl 7:26-30. doi: 10.1016/S0300-2896(10)70043-0. Arch Bronconeumol. 2010. PMID: 21316547 Review. Spanish.
Cited by
-
Pneumonia in low and middle income countries: progress and challenges.Thorax. 2013 Nov;68(11):1052-6. doi: 10.1136/thoraxjnl-2013-204247. Epub 2013 Aug 16. Thorax. 2013. PMID: 23956020 Free PMC article. Review.
-
Real-world Biapenem vs. Meropenem in the treatment of severe community-acquired pneumonia in children: A propensity score matching analysis.Front Pediatr. 2022 Nov 21;10:1047595. doi: 10.3389/fped.2022.1047595. eCollection 2022. Front Pediatr. 2022. PMID: 36479282 Free PMC article.
-
Impact of viral infections in children with community-acquired pneumonia: results of a study of 17 respiratory viruses.Influenza Other Respir Viruses. 2013 Jan;7(1):18-26. doi: 10.1111/j.1750-2659.2012.00340.x. Epub 2012 Feb 13. Influenza Other Respir Viruses. 2013. PMID: 22329841 Free PMC article.
-
Comparison between diagnosis and treatment of community-acquired pneumonia in children in various medical centres across Europe with the United States, United Kingdom and the World Health Organization guidelines.Pneumonia (Nathan). 2016 May 2;8:5. doi: 10.1186/s41479-016-0005-y. eCollection 2016. Pneumonia (Nathan). 2016. PMID: 28702285 Free PMC article.
-
Pentraxin 3 as a clinical marker in children with lower respiratory tract infection.Pediatr Pulmonol. 2016 Jan;51(1):42-8. doi: 10.1002/ppul.23199. Epub 2015 Apr 1. Pediatr Pulmonol. 2016. PMID: 25832310 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous